Detalles de la búsqueda
1.
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Blood
; 140(13): 1470-1481, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35849650
2.
Inverse Correlation between the Atrial Fibrillatory Rate and the Ventricular Repolarization Time: Observations at Baseline and after an Intravenous Infusion of a Combined Potassium and Sodium Current Blocker.
Ann Noninvasive Electrocardiol
; 21(3): 236-45, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26246430
3.
A randomized invasive cardiac electrophysiology study of the combined ion channel blocker AZD1305 in patients after catheter ablation of atrial flutter.
J Cardiovasc Pharmacol
; 56(3): 300-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20588189
4.
Effects of a selective glucocorticoid receptor modulator (AZD9567) versus prednisolone in healthy volunteers: two phase 1, single-blind, randomised controlled trials.
Lancet Rheumatol
; 2(1): e31-e41, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258274
5.
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
Clin Drug Investig
; 39(8): 765-773, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31140114
6.
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
Contemp Clin Trials
; 85: 105835, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446143
Resultados
1 -
6
de 6
1
Próxima >
>>